Brief: Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
22/05/2024 13:44
May 22 (Reuters) - Optimi Health Corp OPTI.CD :
* OPTIMI HEALTH, ATMA SIGN LETTER OF INTENT TO ADVANCE PHASE
II
CLINICAL TRIAL GROUP AND INDIVIDUAL ADMINISTRATION PROTOCOL FOR
MAJOR DEPRESSIVE DISORDER
Source text for Eikon: ID:nGNX4mryRf
Further company coverage: OPTI.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Optimi Health
See all newsExplainer: As Trump backs psychedelics research, FDA weighs safety and access standards
Brief: Optimi Health Corp - Trial Initiation Planned For H1 2027, Dosing To Complete By End Of 2027
Brief: Optimi Health Offers 2.4 MLn Common Shares At A Public Offering Price Of US$6.25 Per Share
Brief: Optimi Health Corp Now Sees IPO Of 2.4 Million Common Shares
Trump's psychedelic drug order boosts investor interest with promise of faster reviews